Inflammatory Response as a Prognostic Factor of Recurrence of Atrial Fibrillation After Ablation

Medical University of Warsaw120 enrolled

Overview

The aim of this study is to evaluate inflammatory response as a prognostic factor of atrial fibrillation recurrency after ablation. Inflammatory response will be assessed by double measurement of C-reactive protein, fibroblast growth factor 2 (FGF2), matrix metallopeptidase 8 (MMP8) and body temperature. Dynamics of change of troponin I will be measured additionally. After ablation each patient will be monitored with ECG telemonitoring system for 7 days.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Atrial Fibrillation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * signed consent; * criteria for ablation of atrial fibrillation. Exclusion Criteria: * previous pulmonary veins isolation; * ablation other than pulmonary veins isolation during the procedure; * atrial fibrillation at the beginning of ablation procedure; * usage of 'single shot' devices.

Locations (1)

1st Department of Cariology of Medcial University of Warsaw

Warsaw, Masovian Voivodeship, Poland

RECRUITING

Outcomes

Primary Outcomes

Atrial fibrillation within the first 7 days after ablation

Time frame: within the first 7 days after ablation

Secondary Outcomes

Atrial fibrillation within 6 months after ablation

Time frame: 6 months

Central Contacts

Michał Peller, MD

CONTACT

694 914 962 michalpeller@gmail.com

Krzysztof Ozierański, MD

CONTACT

509 996 947 krzysztof.ozieranski@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.